Hepion Pharmaceuticals, Inc.
HEPA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583771
In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Other share classesCTRVP
13F holders, Q3 2022
Institutional positions in Hepion Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −2 vs. Q2 2022
- Shares held
- 7.15M
- −261.0K (−3.5%) vs. Q2 2022
- Total value
- $3.61M
- −$630.7K (−14.9%) vs. Q2 2022
- New holders
- 5
- 6 more added
- Sold out
- 7
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HEPA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 4 | $1.39K |
| Q1 2025 | 16 | $419.7K |
| Q4 2024 | 22 | $215.4K |
| Q3 2024 | 22 | $338.2K |
| Q2 2024 | 24 | $863.9K |
| Q1 2024 | 25 | $1.77M |
| Q4 2023 | 24 | $2.42M |
| Q3 2023 | 24 | $4.00M |
| Q2 2023 | 23 | $5.43M |
| Q1 2023 | 32 | $5.60M |
| Q4 2022 | 32 | $2.20M |
| Q3 2022 | 32 | $3.61M |
| Q2 2022 | 34 | $4.24M |
| Q1 2022 | 38 | $9.74M |
| Q4 2021 | 43 | $9.00M |
| Q3 2021 | 42 | $11.9M |
| Q2 2021 | 49 | $21.3M |
| Q1 2021 | 45 | $14.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Hepion Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,308,523 | $1.67M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,592,781 | $805.0K | 0.00% | −21,935−1.4% | Reduced |
| Geode Capital Management, LLC | 658,110 | $332.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 313,500 | $158.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 232,100 | $117.0K | 0.00% | −2,500−1.1% | Reduced |
| Susquehanna International Group, LLP | 165,190 | $84.0K | 0.00% | +71,421+76.2% | Added |
| Bank of New York Mellon Corp | 158,217 | $80.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 132,059 | $67.0K | 0.00% | −1,205−0.9% | Reduced |
| PVG Asset Management Corp | 107,915 | $54.5K | 0.21% | +107,915 | New |
| Envestnet Asset Management Inc | 87,541 | $44.0K | 0.00% | +27,487+45.8% | Added |
| Virtu Financial LLC | 67,802 | $34.0K | 0.00% | +44,867+195.6% | Added |
| McAdam, LLC | 62,169 | $31.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 57,534 | $29.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 31,535 | $16.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 31,093 | $16.0K | 0.00% | +6,327+25.5% | Added |
| Two Sigma Advisers, LP | 30,100 | $15.0K | 0.00% | −15,700−34.3% | Reduced |
| Group One Trading, L.P. | 26,236 | $13.0K | 0.00% | +700+2.7% | Added |
| Citadel Advisors LLC | 21,561 | $11.0K | 0.00% | +21,561 | New |
| Tower Research Capital LLC (TRC) | 19,966 | $10.0K | 0.00% | +8,318+71.4% | Added |
| Morgan Stanley | 17,407 | $8.00K | 0.00% | −8,233−32.1% | Reduced |
| Cetera Investment Advisers | 11,273 | $6.00K | 0.00% | +11,273 | New |
| UBS Group AG | 10,800 | $5.00K | 0.00% | +10,800 | New |
| Federation des caisses Desjardins du Quebec | 3,500 | $1.77K | 0.00% | 00.0% | Unchanged |
| Benjamin F. Edwards & Company, Inc. | 1,001 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 506 | $0 | 0.00% | −4−0.8% | Reduced |
| Barclays PLC | 309 | $0 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 485 | $0 | 0.00% | +485 | New |
| IFP Advisors, Inc | 1 | – | – | 00.0% | Unchanged |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −410,189−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −45,108−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −40,445−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −10,090−100.0% | Sold out |
| Amplius Wealth Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1,770−100.0% | Sold out |